Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on ...

The evolution of diabetes technologies has led to the expansion of automated insulin delivery for type 2 diabetes, continuous ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

Lutz Heinemann 1, G. Alexander Fleming 2, John R. Petrie 3, Reinhard W. Holl 4, Richard M. Bergenstal 5 and Anne L. Peters 6 1 Science & Co, Düsseldorf, Germany 2 Kinexum, Harpers Ferry, WV ...

Marvel's new hero, Dyasonic, is a high schooler with type 1 diabetes, battling villains and stigma to show that chronic illness can be a superpower.

Tandem’s Control-IQ+ algorithm powers automated insulin delivery with two different tubed insulin pumps: the t:slim X2 pump and the more compact Mobi pump. Without insurance, both pumps cost $4,000, ...